Synapse - Sergio Giralt

Results (1069)

T cell depletion as an alternative approach for patients 55 years or older undergoing allogeneic stem cell transplantation as curative therapy for hematologic malignancies

Journal Article

Jakubowski, A. A.; Petrlik, E.; Maloy, M.; Hilden, P.; Papadopoulos, E.; Young, J. W.; Boulad, F.; Castro-Malaspina, H.; Tamari, R.; Dahi, P. B.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Co-infections by double-stranded DNA viruses after ex vivo T cell-depleted, CD34(+) selected hematopoietic cell transplantation

Journal Article

Huang, Y. T.; Kim, S. J.; Lee, Y. J.; Burack, D.; Nichols, P.; Maloy, M.; Perales, M. A.; Giralt, S. A.; Jakubowski, A. A.; Papanicolaou, G. A.
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning is associated with favorable outcomes in mixed phenotype acute leukemia

Journal Article

Getta, B. M.; Roshal, M.; Zheng, J.; Park, J. H.; Stein, E. M.; Levine, R.; Papadopoulos, E. B.; Jakubowski, A. A.; Kernan, N. A.; Steinherz, P.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Galinpepimut-S, a WT1-targeting immuno-oncology treatment, induces specific, robust and durable immune responses (IRs) in patients (Pts) with high-risk (HR) multiple myeloma (MM)

Meeting Abstract

Koehne, G.; Devlin, S.; Korde, N.; Mailankody, S.; Heather, L.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Sarlis, N.; more...
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Management of important adverse events associated with inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia

Meeting Abstract

Kebriaei, P.; van Besien, K.; Cutler, C.; de Lima, M.; Giralt, S.; Lee, S.; Marks, D.; Merchant, A.; Stock, W.; Stelljes, M.
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Timing of initiation of defibrotide post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final data from an expanded-access protocol

Meeting Abstract

Richardson, P.; Smith, A.; Antin, J.; Lehmann, L.; Giralt, S.; Liang, W.; Hume, R.; Tappe, W.; Kernan, N.
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Day+100 survival and safety results from a defibrotide expanded-access program for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS): Final results

Meeting Abstract

Kernan, N.; Smith, A.; Antin, J.; Lehmann, L.; Giralt, S.; Ryan, R.; Hume, R.; Tappe, W.; Richardson, P.
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Allogeneic hematopoietic cell transplantation in patients with AML not achieving remission: Potentially curative therapy

Journal Article

Gyurkocza, B.; Lazarus, H. M.; Giralt, S.
Bone Marrow Transplantation (2017)

Fulltext@MSK | Save

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: A randomised, double-blind, phase 3 trial